These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23580062)

  • 1. The roles of immune memory and aging in protective immunity and endogenous reactivation of tuberculosis.
    Guzzetta G; Kirschner D
    PLoS One; 2013; 8(4):e60425. PubMed ID: 23580062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
    Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
    Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates.
    Rodo MJ; Rozot V; Nemes E; Dintwe O; Hatherill M; Little F; Scriba TJ
    PLoS Pathog; 2019 Mar; 15(3):e1007643. PubMed ID: 30830940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.
    Kolibab K; Yang A; Derrick SC; Waldmann TA; Perera LP; Morris SL
    Clin Vaccine Immunol; 2010 May; 17(5):793-801. PubMed ID: 20357059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis.
    Dey B; Jain R; Gupta UD; Katoch VM; Ramanathan VD; Tyagi AK
    PLoS One; 2011; 6(8):e23360. PubMed ID: 21858087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells.
    Lindenstrøm T; Agger EM; Korsholm KS; Darrah PA; Aagaard C; Seder RA; Rosenkrands I; Andersen P
    J Immunol; 2009 Jun; 182(12):8047-55. PubMed ID: 19494330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium tuberculosis multistage antigens confer comprehensive protection against pre- and post-exposure infections by driving Th1-type T cell immunity.
    Ma J; Tian M; Fan X; Yu Q; Jing Y; Wang W; Li L; Zhou Z
    Oncotarget; 2016 Sep; 7(39):63804-63815. PubMed ID: 27566581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T Cells Primed by Live Mycobacteria Versus a Tuberculosis Subunit Vaccine Exhibit Distinct Functional Properties.
    Lindenstrøm T; Moguche A; Damborg M; Agger EM; Urdahl K; Andersen P
    EBioMedicine; 2018 Jan; 27():27-39. PubMed ID: 29249639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling the host immune response to tuberculosis vaccines.
    Fletcher HA
    Vaccine; 2015 Sep; 33(40):5313-5. PubMed ID: 26241949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of CD27 and CCR4 Markers on Specific CD4
    Latorre I; Fernández-Sanmartín MA; Muriel-Moreno B; Villar-Hernández R; Vila S; Souza-Galvão ML; Stojanovic Z; Jiménez-Fuentes MÁ; Centeno C; Ruiz-Manzano J; Millet JP; Molina-Pinargote I; González-Díaz YD; Lacoma A; Luque-Chacón L; Sabriá J; Prat C; Domínguez J
    Front Immunol; 2018; 9():3094. PubMed ID: 30687314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quest for correlates of protection against tuberculosis.
    Bhatt K; Verma S; Ellner JJ; Salgame P
    Clin Vaccine Immunol; 2015 Mar; 22(3):258-66. PubMed ID: 25589549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.
    Abebe F
    Clin Exp Immunol; 2012 Sep; 169(3):213-9. PubMed ID: 22861360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional T Cell Response to DosR and Rpf Antigens Is Associated with Protection in Long-Term Mycobacterium tuberculosis-Infected Individuals in Colombia.
    Arroyo L; Rojas M; Franken KL; Ottenhoff TH; Barrera LF
    Clin Vaccine Immunol; 2016 Oct; 23(10):813-824. PubMed ID: 27489136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond memory T cells: mechanisms of protective immunity to tuberculosis infection.
    Steigler P; Verrall AJ; Kirman JR
    Immunol Cell Biol; 2019 Aug; 97(7):647-655. PubMed ID: 31141205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Memory Immune Response to Tuberculosis.
    Kirman JR; Henao-Tamayo MI; Agger EM
    Microbiol Spectr; 2016 Dec; 4(6):. PubMed ID: 28087940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette-Guérin (BCG) against Mycobacterium tuberculosis.
    Maurya SK; Aqdas M; Das DK; Singh S; Nadeem S; Kaur G; Agrewala JN
    BMC Infect Dis; 2020 Sep; 20(1):677. PubMed ID: 32942991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice.
    McMurry JA; Kimball S; Lee JH; Rivera D; Martin W; Weiner DB; Kutzler M; Sherman DR; Kornfeld H; De Groot AS
    Curr Mol Med; 2007 Jun; 7(4):351-68. PubMed ID: 17584075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune profiling of Mycobacterium tuberculosis-specific T cells in recent and remote infection.
    Mpande CAM; Rozot V; Mosito B; Musvosvi M; Dintwe OB; Bilek N; Hatherill M; Scriba TJ; Nemes E;
    EBioMedicine; 2021 Feb; 64():103233. PubMed ID: 33610126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.